Immunome (IMNM) Capital Expenditures (2019 - 2026)
Immunome (IMNM) posted Capital Expenditures of $2.18 million for Q2 2026, up 140.4% from $905,000 a year earlier but down 27.5% from the prior quarter.
Powered by 
Analysis
Immunome (IMNM) Capital Expenditures (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Immunome was $10.29 million, up 42.3% year-over-year; for FY2025, it came in at $9.69 million, up 35.0% from FY2024.
- Annual Capital Expenditures has increased for four consecutive years, with a five-year compound annual growth rate of 75.2% (FY2020 to FY2025).
- In prior years, Immunome's Capital Expenditures was $7.17 million in FY2024 (+763.2%), $831,000 in FY2023 (+235.1%), $248,000 in FY2022 (+213.9%) and $79,000 in FY2021 (-86.5%).
- Quarterly Capital Expenditures has run from a low of $6,000 in Q1 2022 to a high of $4 million in Q4 2025 over five years.
- On a year-over-year basis, Capital Expenditures increased in four of the last seven quarters, with growth averaging 82.9%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2024, with growth of 589.4%; the weakest was Q1 2022, with a decline of 80.6%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $3 million (Q1 2026), $4 million (Q4 2025) and $1.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Immunome | 2.48 Bn | 453.48 Mn | - | 2.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.18 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 905,000.00 |
| Mar 31, 2025 | 3.67 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 2.34 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 349,000.00 |
| Sep 30, 2023 | 36,000.00 |
| Jun 30, 2023 | 340,000.00 |
| Mar 31, 2023 | 106,000.00 |
| Dec 31, 2022 | 72,000.00 |
| Jun 30, 2022 | 170,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 8,000.00 |
API Access
Immunome Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IMNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "IMNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IMNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();